Sarah L. Rawe

Antitumour and antimalarial activity of artemisinin–acridine hybrids

Michael E. Jones, Amy E. Mercer, Paul A. Stocks et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 57 citations · Full text

Antiparasitic Agent, Medicine, Malaria +4

Enantiomeric 1,2,4‐Trioxanes Display Equivalent in vitro Antimalarial Activity Versus <i>Plasmodium falciparum</i> Malaria Parasites: Implications for the Molecular Mechanism of Action of the Artemisinins

Paul M. O’Neill, Sarah L. Rawe, Kristina Borstnik et al. · ChemBioChem · 2005 · 53 citations

Bioorganic Chemistry, Trioxane Enantiomers, Antiparasitic Agent +19

Synthesis of Novel Migrastatin and Dorrigocin A Analogues from <scp>D</scp>‐Glucal

Guillaume Anquetin, Sarah L. Rawe, Kevin McMahon et al. · Chemistry - A European Journal · 2007 · 23 citations

Medicinal Chemistry, Bioorganic Chemistry, Migrastatin Macrolide Core +12

Synthesis of Novel Macrolactam and Macroketone Analogues of Migrastatin from <scp>D</scp>‐Glucal and Comparison with Macrolactone and Acyclic Analogues: A Dorrigocin A Congener Is a Potent Inhibitor of Gastric Cancer Cell Migration

Guillaume Anquetin, Gareth Horgan, Sarah L. Rawe et al. · European Journal of Organic Chemistry · 2008 · 19 citations

Medicinal Chemistry, Bioorganic Chemistry, Macroketone Analogues +15

Lewis acid catalysed rearrangements of unsaturated bicyclic [2.2.n] endoperoxides in the presence of vinyl silanes; access to novel Fenozan BO-7 analogues

Paul M. O’Neill, Sarah L. Rawe, R. C. STORR et al. · Tetrahedron Letters · 2005 · 11 citations

Vinyl Silanes, Heterocyclic, Lewis Acid +6